Interaction Guide · Research summary

Can I take Lycopus Virginicus with Liothyronine?

Review Lycopus Virginicus with Liothyronine: absorption and effectiveness, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

There is not enough clinical evidence to say that Lycopus virginicus reduces liothyronine absorption or effectiveness. Laboratory findings suggest thyroid-related activity, so a person treated for thyroid disease should have the exact bugleweed preparation reviewed before using it.

What this answer covers

Oral liothyronine and exact Lycopus virginicus preparations. Lycopus europaeus, other botanicals, multiherb mixtures and different extraction methods are not interchangeable evidence.

Supplement or preparation
Lycopus virginicus
Medication ingredient
liothyronine

Where did the concern originate?

Laboratory experiments included extracts of Lycopus virginicus and found effects on thyroid-related enzyme or stimulation systems. These findings make the botanical worth reviewing, but the experiments did not test people taking a liothyronine tablet.

Does inhibiting T4 conversion mean blocking T3?

Not necessarily. One experiment studied conversion of T4 to T3 in rat liver preparations. Liothyronine supplies T3 directly. A result at that conversion step does not by itself demonstrate reduced absorption or reduced action of the administered T3 dose.

Why keep the species and preparation exact?

The studies included several plants, and activity varied with species and extraction method. Some detailed receptor-binding work concerned a different botanical. Those results cannot all be assigned to Lycopus virginicus or converted into a potency estimate for a commercial bugleweed bottle.

What can a consumer reasonably do?

Discuss the plant name, part used, extract and dose with the thyroid prescriber. No clinical dosing interval or reliable combination dose was established by this review. Continue prescribed thyroid treatment and monitoring; this evidence does not justify using bugleweed to offset or replace liothyronine.

Evidence and practical considerations

Absorption & effectiveness

There is not enough clinical evidence to say that Lycopus virginicus reduces liothyronine absorption or effectiveness. Laboratory findings suggest thyroid-related activity, so a person treated for thyroid disease should have the exact bugleweed preparation reviewed before using it.

Exact scope
Oral liothyronine and exact Lycopus virginicus preparations. Lycopus europaeus, other botanicals, multiherb mixtures and different extraction methods are not interchangeable evidence. with oral liothyronine sodium providing the exact liothyronine active moiety
Medication form and route
oral
Timing or duration
During co-use; study-specific durations are retained in the source summaries. No universal duration or dose-response inferred.

What remains uncertain

  • Nonclinical evidence only for the proposed interaction. No direct T3 absorption, human co-use endpoint, dose threshold or validated timing rule. Distinct species and assay mechanisms were explicitly excluded.

Factors that may matter: exact supplement preparation and dose; oral versus nonoral medication route; other formula ingredients; patient thyroid status.

Research conclusion: insufficient evidence · Evidence assessment: very low

Read the supporting source summaries

Source 1: regulatory product label

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: People prescribed oral liothyronine sodium tablets.

T3 dose depends on food, other medicines, clinical response and laboratory results. Table 1 explicitly names resins and bile-acid sequestrants, but does not name the mineral, fiber, soy or botanical pairs evaluated here.

How this applies: Confirms exact liothyronine active moiety, not levothyroxine. Supports monitored individualized treatment; mineral and botanical conclusions require other sources. Exact package scope: Oral liothyronine and exact Lycopus virginicus preparations. Lycopus europaeus, other botanicals, multiherb mixtures and different extraction methods are not interchangeable evidence.

Absence of a named interaction is not evidence of absence. The four-hour resin instruction cannot automatically be transferred to minerals or fiber.

Source 2: in vitro rat-liver enzyme experiment

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Rat liver microsomes, not people taking thyroid medication.

Extracts inhibited T4 deiodination in vitro; activity depended on species and extraction method.

How this applies: Exact botanical species appears, but inhibition of conversion from T4 to T3 does not show that already-administered liothyronine is blocked. Exact package scope: Oral liothyronine and exact Lycopus virginicus preparations. Lycopus europaeus, other botanicals, multiherb mixtures and different extraction methods are not interchangeable evidence.

No human exposure, oral absorption or prescribed T3 effect measured. The abstract cannot establish a consumer dose or product potency.

Source 3: nonclinical thyroid receptor and immunoglobulin experiments

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Laboratory systems using Graves immunoglobulins and thyroid membranes.

Antithyrotropic extracts inhibited TSH/Graves-IgG-related activity. Detailed direct-binding experiment in abstract used Lithospermum officinale.

How this applies: Mechanistic rationale only, explicitly excluding silent transfer of results from L. europaeus or Lithospermum. Exact package scope: Oral liothyronine and exact Lycopus virginicus preparations. Lycopus europaeus, other botanicals, multiherb mixtures and different extraction methods are not interchangeable evidence.

Not a clinical trial or T3 receptor experiment. Species-specific results cannot all be assigned to L. virginicus.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Replaces the imported reduced-effectiveness claim with insufficient evidence and explains why T4-conversion experiments cannot establish a T3 interaction.
Research summary published

Article revision: 26024d42b5a5ccbb

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.